Drug intelligence / Profile preview

Betula nigra pollen extract

Development stage
Unknown
Lead developer
ALK Abelló
Modality
Sublingual Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics, Subcutaneous Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics
Administration
Intradermal, Percutaneous, Subcutaneous, Sublingual
01

Overview

Betula nigra pollen extract is a non-standardized biologic allergenic extract derived from the pollen of the river birch tree (Betula nigra). [5] It is indicated for both the diagnosis (via skin testing) and treatment (via immunotherapy) of individuals with immediate hypersensitivity allergies to river birch pollen. [3] The product works through allergen-specific immunotherapy, a process that desensitizes the patient's immune system to the specific pollen allergens by administering gradually increasing doses of the extract, which can reduce or eliminate allergic symptoms. [1, 3] This treatment is typically administered via percutaneous, subcutaneous, or intradermal injection. It is marketed by several companies, including Allergy Laboratories, Inc. under the brand name River Birch Pollen.

Brand names
River Birch Pollen
Other names
River birch pollenBetula nigra pollen
02

Targets

IgE (Immunoglobulin E)

Beyond the preview

Go deeper on Betula nigra pollen extract.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Betula nigra pollen extract.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call